Belgium mRNA specialist Quantoom Biosciences and biologics manufacturing specialist Univercells inked a partnership deal with the Oswaldo Cruz Foundation (Fiocruz) in a move aimed at expanding the ...

With the novel coronavirus continuing its global spread, drugmakers are pouring massive resources into developing targeted therapies and vaccines. Now, a new CDMO from Belgium's Univercells is hoping ...

BRUSSELS, Belgium--(BUSINESS WIRE)--Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges, has announced ...

Univercells Technologies, acquired in June 2023 by Donaldson, says that the Gene Therapy Program at the University of Pennsylvania (GTP) is expanding its evaluation agreement aimed at determining the ...

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it ...

The scale-X™ nitro controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months. The new controller complements the existing NevoLine™ ...

NIVELLES, Belgium--(BUSINESS WIRE)--Donaldson (NYSE: DCI), a global provider of innovative biomanufacturing technologies, with its Univercells Technologies business, announces that the Gene Therapy ...

Codagenix and Univercells have partnered on a research collaboration to pursue an undisclosed, high-priority human vaccine target. Codagenix, a clinical-stage biotechnology company developing ...

Univercells and Altamira Therapeutics are collaborating on nanoparticle-delivered mRNA vaccines, while Andelyn Biosciences and Grace Science are partnering on novel therapies for NGLY1 deficiency. On ...

MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today ...

(MENAFN- Andrew Lloyd & Associates) Brussels, Belgium & Evry, France, January 6, 2022 - Univercells S.A. (Univercells) today announces its acquisition of SynHelix, a biotechnology company that aims to ...